Page 16 - ஆய்வகங்கள் அல்ட்ராசவுண்ட் வடிகுழாய் விற்பனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆய்வகங்கள் அல்ட்ராசவுண்ட் வடிகுழாய் விற்பனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆய்வகங்கள் அல்ட்ராசவுண்ட் வடிகுழாய் விற்பனை Today - Breaking & Trending Today

Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.


Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.
Company or
Canntab ), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its 2
nd (second) delivery of (2) (two) additional SKU s ordered by MediPharm Labs Corp ( MediPharm Labs ) (TSX: LABS) (OTCQX: MEDIF) including 12.5mg CBD caplets (hard tablets in the shape of capsules) and 25mg CBD caplets for approximately $550,000.00. Canntab has now fulfilled 80% of the purchase amount contracted under the wholesale table purchase agreement entered into by the Company and MediPharm Labs in June, 2020. ....

United States , Frank Candido , Larry Latowsky , Canntab Therapeutics Inc , Company Or Canntab , Canntab Therapeutics Limited , Canntab Therapeutics Limited Larry Latowsky , Canntab Therapeutics Limited Richard Goldstein , Cannabis Research Licence , Neither The Canadian Securities Exchange , Clinical Research Organization , Medipharm Labs Corp , Canadian Securities Exchange , Frankfurt Stock Exchange , Newsfile Corp , Investor Relations Canntab Therapeutics , Health Canada , Business Development , Therapeutics Limited , Medipharm Labs , Chief Executive Officer , Canntab Therapeutics , Canadian Licensed Producer , Cannabis Standard Processing , Medical Purposes Licence , Industrial Hemp Licence ,

Global Clinical Chemistry Analyzers Market Report 2021: Availability of Refurbished Products is Expected to Limit Market Growth

Dublin, March 02, 2021 (GLOBE NEWSWIRE) The "Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Global Clinical Chemistry Analyzers Market Size is Projected to Reach USD 15.2 Billion by 2026 from USD 12.3 Billion in 2021, at a CAGR of 4.3% Market growth is driven by factors such as the rising geriatric population and the increasing prevalence of chronic & lifestyle diseases, growing adoption of Point-of-Care testing devices and rising demand for laboratory automation. On the other hand, high capital investment, shortage of clinical laboratory technicians, and the availability of refurbished products is expected to limit market growth to a certain extent in the coming years. The reagents accounted for the h ....

Market Growth , Clinical Chemistry , Lifestyle Diseases , Lipid Profile , Fully Automated Analyzers , சந்தை வளர்ச்சி , மருத்துவ வேதியியல் , வாழ்க்கை நோய்கள் , கொழுமியம் ப்ரொஃபைல் , முழுமையாக தானியங்கி பகுப்பாய்விகள் ,

Global Hemoglobin Testing Industry

Global Hemoglobin Testing Market to Reach $1. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Hemoglobin Testing estimated at US$989. 3 Million in the year 2020, is projected to reach a revised size of US$1.New York, March 02, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report "Global Hemoglobin Testing Industry" - https://www.reportlinker.com/p05956939/?utm source=GNW 6 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Hospitals, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$591.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Research Centers segment is readjusted to a revised 6.5% CAGR for the next 7-year period. The U.S. Market is Estimated at $267.7 Million, While China is Forecast to Grow at 10.2% CAGR The Hemoglobin Testing market in the U.S ....

Research Centers , Latin America , Geographic Region , Asia Pacific , ஆராய்ச்சி மையங்கள் , லத்தீன் அமெரிக்கா , புவியியல் பகுதி , ஆசியா பெஸிஃபிக் ,

COVID Patients May Never Know If They Contract A Variant (VIDEO)


March 2, 2021
March 2, 2021
Federal rules restrict labs from telling patients and their doctors if they ve been infected by a COVID variant.
SHOW TRANSCRIPT ....

Covid 19 , Kaiser Health News , கைசர் ஆரோக்கியம் செய்தி ,